CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Baccalaureate 2024: 52.39% success in the Namentenga

The province of Namentenga recorded on Wednesday July 3, 2024 a success rate of 52.39% compared to 28.10% in 2023, following the final results of the baccalaureate session 2024.

The overall final result at the provincial level for the baccalaureate f…

Ousmane Boly declares his candidacy for president of the FBF

Ouagadougou: Ousmane Boly declared Thursday, in a press release sent to the AIB, his candidacy for the presidency of the Burkinabè Football Federation to ‘ build with everyone, the solid foundations of Burkinabè football sustainably efficient’.

‘We h…